Lepu Medical Technology (Beijing) Co., Ltd. | ClinicalTrials HQ

6 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
EGFR-ADC (Becotatug Vedotin) Combined With PD-1 Inhibitor (Pucotenlimab) in Neoadjuvant Treatment of Advanced Penile Cancer	Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, penile cancer, penile disorder, penile neoplasm	Recruiting	Phase 2	2026-07-29		NCT07518979
MRG003 Plus HX008 as First-Line Treatment for EGFR-Positive Locally Advanced or Metastatic Penile Squamous Cell Carcinoma	Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, penile cancer, penile disorder, penile neoplasm	Recruiting	Phase 1	2026-04-07		NCT07054307
Clinical Trial Comparing Induction Treatment With EGFR-ADC MRG003 Alone or in Combination With the Anti PD1 Pucotenlimab, Followed by Radiochemotherapy in Locally Advanced Squamous Cell Cancers of the Head and Neck	Locally Advanced Head and Neck Squamous Cell Carcinoma	Recruiting	Phase 2	2026-04-07		NCT06959108
Pembrolizumab + MRGOO3 as Neoadjuvant in NPC	nasopharyngeal carcinoma	Not yet recruiting	Phase 2	2025-12-05		NCT07267338
To Evaluate the Safety and Efficacy of a Single-Use IVUS Ablation for Primary Hypertension	cardiovascular disorder, essential hypertension, hypertensive disorder, vascular disorder	Recruiting	Not applicable	2025-07-04		NCT07051811
Optimized Antiplatelet Therapy in Patients With CHD After Implantation of NeoVas™ BRS System	cardiovascular disorder, coronary artery disorder, heart disorder, myocardial ischemia, vascular disorder	Not yet recruiting	Not applicable	2021-08-06		NCT04995159